CPRT has spent the week in an unusual bind: its shares gained 4% but remain close enough to a critical index threshold that a single bad week could trigger $2.4 billion of forced selling, even as the company's own buyback program is running at the highest pace in its history. The index pressure is the most concrete near-term mechanical risk on the stock. ORTEX puts the probability…
CPRT downgraded to Hold by HSBC; analyst Wesley Brooks sets $36 price target, down from Buy rating. Stock at $30.82, down 3.8% over past week.
Key data as of 9 Nov 2026
CPRT heads into its September 3 earnings date with a contradictory setup: the stock is up 19% over the past month and 5.8% this week alone, yet short sellers have been quietly rebuilding positions rather than…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CPRT — free to start on ORTEX.
Sign up for free →Open CPRT on ORTEX